CureVac/$CVAC
About CureVac
Ticker
Industry
Employees
CureVac Metrics
$884M
-
-$1.27
2.59
-
Price and volume
Market cap
$884M
Beta
2.59
52-week high
$5.28
52-week low
$2.22
Average daily volume
946K
Financial strength
Current ratio
2.287
Quick ratio
2.194
Long term debt to equity
9.02
Total debt to equity
10.367
Management effectiveness
Return on assets (TTM)
-24.52%
Return on equity (TTM)
-54.30%
Valuation
Price to revenue (TTM)
13.085
Price to book
2.35
Price to tangible book (TTM)
2.53
Price to free cash flow (TTM)
-2.609
Growth
Revenue change (TTM)
75.11%
Earnings per share change (TTM)
-15.72%
3-year revenue growth (CAGR)
14.71%
3-year earnings per share growth (CAGR)
-15.34%
What the Analysts think about CureVac
Analyst Ratings
CureVac Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
CureVac Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
CureVac News
FAQs
What’s the current market cap for CureVac stock?
What is the P/E ratio for CureVac stock?
Does CureVac stock pay dividends?
No, CureVac (CVAC) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next CureVac dividend payment date?
CureVac (CVAC) stock does not pay dividends to its shareholders.
What is the beta indicator for CureVac?
CureVac (CVAC) has a beta rating of 2.59. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.